Exemestane (Alchemy)

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Exemestane 25mg

Pieejams no:

Alchemy Health Limited

Deva:

25 mg

Zāļu forma:

Film coated tablet

Kompozīcija:

Active: Exemestane 25mg Excipient: Colloidal silicon dioxide Crospovidone Hypromellose   Macrogol 400 Macrogol 6000 Magnesium stearate Mannitol Microcrystalline cellulose Polysorbate 80 Purified talc Sodium starch glycolate Titanium dioxide

Receptes veids:

Prescription

Ārstēšanas norādes:

EXEMESTANE is indicated for: · the adjuvant treatment of postmenopausal women with oestrogen receptor positive or receptor unknown early breast cancer after initial adjuvant tamoxifen to reduce the risk of recurrence (distant and loco-regional) and contralateral breast cancer · the treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy · the third-line hormonal treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease progressed following treatment with anti-oestrogens and either non-steroidal aromatase inhibitors or progestins.

Produktu pārskats:

Package - Contents - Shelf Life: Blister pack, aluminium PVC/PVDC, contained in cardboard carton - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Autorizācija datums:

2020-09-25